Ana M. Battastini-Oliveira
Porto Alegre, RS, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Assessing Ecto-5'-Nucleotidase/CD73 Expression and Malignancy Parameters in Early- and Late- Passage C6 Glioma Cells.
Journal: Neurochemical research
Published: February 10, 2025
Preclinical evaluation of bozepinib in bladder cancer cell lines: modulation of the NPP1 enzyme.
Journal: Purinergic signalling
Published: May 05, 2023
Lymphocytes from B-acute lymphoblastic leukemia patients present differential regulation of the adenosinergic axis depending on risk stratification.
Journal: Discover oncology
Published: October 18, 2022
Development of bozepinib-loaded nanocapsules for nose-to-brain delivery: preclinical evaluation in glioblastoma.
Journal: Nanomedicine (London, England)
Published: September 15, 2021
EGFRvIII peptide nanocapsules and bevacizumab nanocapsules: a nose-to-brain multitarget approach against glioblastoma.
Journal: Nanomedicine (London, England)
Published: July 27, 2021
Post-weaning social isolation impairs purinergic signaling in rat brain.
Journal: Neurochemistry international
Published: January 18, 2021
New pharmacological findings linked to biphenyl DHPMs, kinesin Eg5 ligands: anticancer and antioxidant effects.
Journal: Future medicinal chemistry
Published: June 10, 2020
1,2,3-Triazole tethered 2-mercaptobenzimidazole derivatives: design, synthesis and molecular assessment toward C6 glioma cell line.
Journal: Future medicinal chemistry
Published: March 21, 2020
Bipolar disorder and 1513A>C P2RX7 polymorphism frequency.
Journal: Neuroscience letters
Published: August 27, 2018
Effect of N-1 arylation of monastrol on kinesin Eg5 inhibition in glioma cell lines.
Journal: MedChemComm
Published: February 19, 2018
Ecto-5'-nucleotidase/CD73 contributes to the radiosensitivity of T24 human bladder cancer cell line.
Ecto-5'-nucleotidase/CD73 contributes to the radiosensitivity of T24 human bladder cancer cell line.
Journal: Journal of cancer research and clinical oncology
Published: August 16, 2017
Alpha-bisabolol Promotes Glioma Cell Death by Modulating the Adenosinergic System.
Journal: Anticancer research
Published: January 25, 2017
Last Updated: 09/26/2026